Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
Services professionnels
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Explore the 2026 pressure-sensitive adhesive materials landscape for electronics and medical devices: key chemistries, application domains, regulatory drivers, and IP trends.
Article | Rapport Cytosine base editor (CBE) patent and technology landscape 2026: key assignees, delivery strategies, deaminase engineering, and emerging clinical directions.
Article | Rapport Key technical considerations for designing high-voltage solid-state circuit breakers (SSCBs) for DC microgrid protection — topologies, semiconductors, and fault strategies.
Article | Rapport GDF15 analogues and the GFRAL receptor pathway are reshaping obesity drug development. Explore WVE-007, Wave Life Sciences, and the IP landscape for this novel mechanism.
Article | Rapport Efruxifermin's Phase 2b BALANCED trial showed 41% fibrosis improvement in MASH cirrhosis. Explore Akero's FGF21 IP estate and Roche's post-acquisition strategy.
Article | Rapport Map the 2026 single cell epigenomics landscape: scATAC-seq, CUT&Tag, spatial epigenomics, multi-modal profiling, and AI-driven bioinformatics for clinical translation.
Article | Rapport Explore how Design for Reliability and Design for Testability differ in aerospace avionics — from FMEA and fault tolerance to built-in test and DO-254 compliance.
Article | Rapport Mapping the 2026 AV occupancy prediction patent landscape: OGMs, trajectory forecasting, planning-integrated prediction, and who's filing where across 70+ records.
Article | Rapport A research guide to bio-based epoxy resin materials for composites and coatings in 2026: key technology classes, search strategies, and IP intelligence sources.
Article | Rapport How Lilly's Ventyx acquisition reshapes the TYK2 and JAK inhibitor race. Analysis of VTX958's allosteric mechanism, immune pathway portfolio, and competitive positioning.
Article | Rapport Explore the core engineering challenges of scalable roll-to-roll manufacturing for perovskite photovoltaic modules — from deposition uniformity to encapsulation.
Article | Rapport Circular RNA therapeutics patent landscape 2026: key assignees, technology clusters, application domains, and strategic IP white spaces across EP, IL, and SG jurisdictions.
Article | Rapport Compare open-circuit voltage relaxation and electrochemical impedance spectroscopy for battery state estimation — methods, trade-offs, and BMS applications explained.
Article | Rapport Explore how a Biogen acquisition of Apellis Pharmaceuticals and its Syfovre and Empaveli complement portfolio could reshape rare disease pipeline strategy.
Article | Rapport How inert anodes, hydrogen substitution, and renewable energy integration are reshaping the 1.1 Gt CO₂/yr aluminum smelting industry by 2026.